Anti‐tumour necrosis factor biological therapies for the treatment of uveitic macular oedema (UMO) for non‐infectious uveitis

BACKGROUND: Non‐infectious uveitis describes a heterogenous group of ocular disorders characterised by intraocular inflammation in the absence of infection. Uveitis is a leading cause of visual loss, most commonly due to uveitic macular oedema (UMO). Treatment is aimed at reducing disease activity b...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cochrane Database Syst Rev
Hlavní autoři: Barry, Robert J, Tallouzi, Mohammad O, Bucknall, Nick, Mathers, Jonathan M, Murray, Philip I, Calvert, Melanie J, Moore, David J, Denniston, Alastair K
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Ltd 2018
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6516996/
https://ncbi.nlm.nih.gov/pubmed/30562409
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012577.pub2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky